135 related articles for article (PubMed ID: 8524477)
1. Five years' experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis.
Kriaa F; Laurian Y; Hiesse C; Tchernia G; Charpentier B
Nephrol Dial Transplant; 1995; 10 Suppl 6():108-10. PubMed ID: 8524477
[TBL] [Abstract][Full Text] [Related]
2. Five year experience with protein A immunoadsorption in patients with allo/auto-antibodies (anti-HLA antibodies, autoimmune bleeding disorders) and transplant patients with relapsing focal glomerular sclerosis.
Kriaa F; Laurian Y; Hiesse C; Tchernia G; Charpentier B
Transplant Proc; 1995 Feb; 27(1):1031-2. PubMed ID: 7878790
[No Abstract] [Full Text] [Related]
3. Immunoadsorption of anti-HLA antibodies for highly sensitized patients awaiting renal transplantation.
Hiesse C; Kriaa F; Rousseau P; Farahmand H; Bismuth A; Fries D; Charpentier B
Nephrol Dial Transplant; 1992; 7(9):944-51. PubMed ID: 1328943
[TBL] [Abstract][Full Text] [Related]
4. Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients.
Kupin WL; Venkat KK; Hayashi H; Mozes MF; Oh HK; Watt R
Transplantation; 1991 Feb; 51(2):324-9. PubMed ID: 1994523
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic apheresis in renal transplantation; current practices.
Keith DS
J Clin Apher; 2014 Aug; 29(4):206-10. PubMed ID: 24863952
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the Combination of Immunoadsorption and Rituximab for Treatment in a Case of Severe Focal and Segmental Glomerulosclerosis Recurrence after Renal Transplantation.
Martin-Moreno PL; Rifon J; Errasti P
Blood Purif; 2018; 46(2):90-93. PubMed ID: 29672314
[TBL] [Abstract][Full Text] [Related]
8. How to deal with the hyperimmunized potential recipients.
Charpentier BM; Hiesse C; Kriaa F; Rousseau P; Farahmand H; Bismuth A; Fries D
Kidney Int Suppl; 1992 Oct; 38():S176-81. PubMed ID: 1405372
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal removal of anti-HLA antibodies in transplant candidates.
Hakim RM; Milford E; Himmelfarb J; Wingard R; Lazarus JM; Watt RM
Am J Kidney Dis; 1990 Nov; 16(5):423-31. PubMed ID: 2239932
[TBL] [Abstract][Full Text] [Related]
10. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
[TBL] [Abstract][Full Text] [Related]
11. [Protein A immunoadsorption al a new apheresis procedure for elimination of HLA antibodies].
Schneidewind J; Gliesche T; Sehland D; Ramlow W; Wolfsdorff B; Bast R; Wegener S; Decker S; Schmidt R
Beitr Infusionsther Transfusionsmed; 1994; 32():360-5. PubMed ID: 9480125
[TBL] [Abstract][Full Text] [Related]
12. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
[TBL] [Abstract][Full Text] [Related]
13. Anti-HLA antibodies depletion on protein A-sepharose columns in hyperimmunized patients awaiting renal transplantation.
Kriaa F; Rousseau P; Hiesse C; Farahmand H; Brocard JF; Rieu P; Lantz O; Farquet C; Bismuth A; Benoit G
Ann Med Interne (Paris); 1992; 143 Suppl 1():39-42. PubMed ID: 1300886
[TBL] [Abstract][Full Text] [Related]
14. [Immunoadsorption of anti-HLA antibodies on protein A-sepharose columns in hyperimmunized recipients waiting for transplantation].
Kriaa F; Hiesse C; Farahmand H; Bismuth A; Charpentier B
Ann Med Interne (Paris); 1994; 145(5):324-7. PubMed ID: 7985941
[TBL] [Abstract][Full Text] [Related]
15. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
[TBL] [Abstract][Full Text] [Related]
16. In vitro removal of anti-HLA IgG antibodies from highly sensitized transplant recipients by immunoadsorption with protein A and protein G sepharose columns: a comparison.
Barocci S; Nocera A
Transpl Int; 1993 Jan; 6(1):29-33. PubMed ID: 8452629
[TBL] [Abstract][Full Text] [Related]
17. Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis.
Beaudreuil S; Zhang X; Kriaa F; Dantal J; Francois H; Vazquez A; Charpentier B; Lorenzo HK; Durrbach A
Nephrol Dial Transplant; 2014 Feb; 29(2):458-63. PubMed ID: 24235085
[TBL] [Abstract][Full Text] [Related]
18. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
[TBL] [Abstract][Full Text] [Related]
19. Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome.
Dantal J; Godfrin Y; Koll R; Perretto S; Naulet J; Bouhours JF; Soulillou JP
J Am Soc Nephrol; 1998 Sep; 9(9):1709-15. PubMed ID: 9727380
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrence of focal segmental glomerular sclerosis after kidney transplantation with plasma exchange and immunoadsorption.
Ponikvar R; Bren A; Kandus A; Buturović Ponikvar J
Transplant Proc; 2001; 33(7-8):3365-7. PubMed ID: 11750439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
